
Researchers show that Paxlovid remains highly effective on omicron variants
Researchers have conducted one of the first studies to examine the effectiveness of nirmatrelvir-ritonavir (Paxlovid) in non-hospitalized patients during an omicron period of the COVID-19 pandemic that includes BA.4 and BA.5 ...
Feb 10, 2023
2
84